Investing Profile

Paul Walker

VCInvestor
General Partner at New Enterprise Associates (NEA)
nea.com/team/paul-walkerMenlo Park, California
Photo of Paul Walker, General Partner at New Enterprise Associates (NEA)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$2.0M - $50.0M
$25.0M
24
$6.2B
CompanyStageDateRound SizeTotal Raised
Phathom Pharmaceuticals
Post Ipo EquityMay 2023$150M
$150M
Co-investors: Blake Wu (New Enterprise Associates (NEA))
Allakos
Post Ipo EquitySep 2022$150M
Series BDec 2017$100M
$290M
Co-investors: Farah Champsi (InterWest)
Regulus Therapeutics
Post Ipo EquityNov 2021$35M
Post Ipo EquityJan 2017
$35M
Savara Pharmaceuticals
Post Ipo EquityMar 2021$130M
$130M
Co-investors: Blake Wu (New Enterprise Associates (NEA))
Geron
Post Ipo EquityMay 2020$150M
$150M
erytech
Post Ipo EquityJan 2020
Xenon Pharmaceuticals
Post Ipo EquitySep 2018$63M
$63M
Co-investors: Blake Wu (New Enterprise Associates (NEA))
CTI BioPharma
Post Ipo EquityFeb 2018$69M
$69M